Fierce Pharma
OCTOBER 10, 2024
As Roche comes under competitive pressure on its breast cancer business, the Swiss company hopes a new drug will add a 2-billion-Swiss-francs luster to the once high-flying portfolio. | As Roche comes under competitive pressure on its breast cancer business, the Swiss company hopes a new drug will add a 2-billion-Swiss-francs luster to the once high-flying portfolio.
Pharma IQ
OCTOBER 10, 2024
Discover how Enterprise Architecture is transforming healthcare operations, enhancing patient care, and addressing technical debt in the industry.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
OCTOBER 10, 2024
Activist investor Starboard accuses Pfizer of strong-arming former execs into backing CEO Bourla ahead of strategy meeting zbecker Thu, 10/10/2024 - 11:03
MedCity News
OCTOBER 10, 2024
During the Reuters Total Health conference, two healthcare leaders debated whether AI has the potential to reduce healthcare disparities. One argued that the technology is not there yet, while the other argued that it’s about how people use AI. The post Can AI Reduce Healthcare Disparities? Health Execs Debate appeared first on MedCity News.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Fierce Pharma
OCTOBER 10, 2024
As Novo Holdings hopes to close its $16.5 billion acquisition of CDMO Catalent by the end of the year, the deal is facing a fresh round of lawmaker scrutiny. | In a letter to the chair of the U.S. Federal Trade Commission, Lina Khan, Sen. Elizabeth Warren is calling on the antitrust agency to “carefully scrutinize” Novo Holding’s multibillion-dollar bid for CDMO Catalent.
PharmaTech
OCTOBER 10, 2024
Five speakers discussed the impact of the COVID-19 pandemic, the rise of artificial intelligence, more women in leadership tracks in the industry, and various emerging technologies.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
OCTOBER 10, 2024
The idea is to harness the power of digital tools and cloud-based systems to create solutions that understand the root cause of healthcare needs, which will ultimately revolutionize care delivery, improve outcomes and reduce costs. The post Healthcare’s Silver Lining: The Promise of Building a Health System in the Cloud appeared first on MedCity News.
Fierce Pharma
OCTOBER 10, 2024
Switzerland’s Competition Commission (COMCO) has dropped its investigation into Novartis’ use of patent actions to quell competition for Cosentyx.
European Pharmaceutical Review
OCTOBER 10, 2024
A draft joint EU network strategy to 2028 has been published by the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA). This is updated strategy replaces the original five-year strategy, which was developed to cover from 2021 to 2025 (EMANS 2025). Revised strategy – adapting to change The draft strategy covers the following focus areas up to 2028: Accessibility to support pathways for medicine access in the EU Leveraging data, digitalisation and artificial intelligen
MedCity News
OCTOBER 10, 2024
Telehealth should serve as a tool for leveling the playing field, ensuring that every person has access to the care they deserve, no matter their socioeconomic status or zip code. The post The Power of “Techquity”: How Telehealth Can Help Promote Health Equity appeared first on MedCity News.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
pharmaphorum
OCTOBER 10, 2024
Media personality Nadia Sawalha is heading a fundraising effort to launch an appeal against NICE's recent rejection of a breast cancer therapy Enhertu.
PharmaTech
OCTOBER 10, 2024
Pharmaceutical Technology sat down with Niloufar Salehi, advisor at Eli Lilly & Company, to talk about the session she is moderating at AAPS PharmSci 360 2024, Symposium: An Accelerated Development of Poorly Soluble Drugs Using Predictive Tool.
pharmaphorum
OCTOBER 10, 2024
Starboard Value alleges former Pfizer execs Ian Read and Frank D'Amelio were bullied into lending their support to current management
MedCity News
OCTOBER 10, 2024
Booster Therapeutics’ small molecules activate the 20S proteasome, a component of cells that gets rid of misfolded proteins. Parkinson’s and Alzheimer’s are potential disease targets for the startup, which launched with $15 million in seed financing. The post Startup Booster Therapeutics Launches to Usher In Next Wave of Protein-Degrading Drugs appeared first on MedCity News.
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
pharmaphorum
OCTOBER 10, 2024
Ono Pharma and Boehringer Ingelheim both added to their cancer pipelines, licensing drugs from LigaChem Bio and Circle Pharma, respectively.Ono's deal with South Korean antibody-drug conjugate (ADC) specialist LigaChem is worth up to $700 million and covers a license to a preclinical-stage candidate for solid tumours, as well as an R&D collaboration to seek out other ADC candidates.
Quantified
OCTOBER 10, 2024
What is an SKO? Key Goals of an SKO Alignment on Objectives Education on New Products Motivation and Recognition Training on New Strategies Step-by-Step Guide to a Successful SKO Step 1: Define Your SKO Purpose Step 2: Plan Interactive and Engaging Activities Step 3: Skip Remote Presentations for Maximum Engagement Step 4: Leverage AI-Powered Simulations for Training Step 5: Involve Executives Throughout the Event Step 6: Follow Up with Ongoing Training and SPIFFs Final Thoughts What is an SKO?
PharmaTech
OCTOBER 10, 2024
Pharmaceutical Technology Europe sat down with Joan Bassa, Human Health Business Unit Director at Bioiberica, to talk about the history of heparin, its uses in pharmaceuticals, and what heparinoids have to offer the industry.
Pharmaceutical Technology
OCTOBER 10, 2024
Germany-based Merck KGaA has announced the launch of a new €290m ($317.6m) biosafety testing facility in Rockville, Maryland, US.
PharmaTech
OCTOBER 10, 2024
Rafael Ferrer, interim chief business officer at Acino, talked about his company's recent efforts to reach customers in Africa, the Middle East, and most recently, Latin America.
Pharmaceutical Commerce
OCTOBER 10, 2024
Lucy Alexander, capabilities lead, global supply chain and strategy, AstraZeneca, discusses critical conversations that supply chain teams and partners must partake in during API sourcing at LogiPharma USA 2024.
PharmaTech
OCTOBER 10, 2024
Enzene Biosciences CEO Himanshu Gadgil talked about fully connected continuous manufacturing's role in providing equity for biotech companies that may not normally be able to afford such services.
PharmaTimes
OCTOBER 10, 2024
Teclistamab offers hope for patients exhausting treatment options
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
pharmaphorum
OCTOBER 10, 2024
EVERSANA partners Oracle on pharmacovigilance platform Phil.
PharmaTimes
OCTOBER 10, 2024
Sheffield cardiologists demonstrate cutting-edge TAVI procedure
pharmaphorum
OCTOBER 10, 2024
RNAI startup City Therapeutics raises $135m, with Purespring, Judo Bio, GEMMABio, and Basecamp Research also completing financings this week.
Rep-Lite
OCTOBER 10, 2024
In-house medical recruiters play a critical role in healthcare organizations, ensuring that hospitals and clinics are staffed with qualified professionals. However, behind the scenes, these recruiters face a multitude of challenges that can often lead to frustration, burnout, and inefficiency. In this article, Rep-Lite aims to help you understand these pain points to better assist you in recognizing the evolving nature of medical recruitment and addressing the complexities that impact both recru
PharmaTech
OCTOBER 10, 2024
Get a glimpse of the power and popularity behind the PDA Pharmaceutical Microbiology Conference from two planning committee members, Julia Marre, PhD (Associate Director, Scientific and Regulatory Affairs at Pocket Naloxone Corp) and Dawn Watson (Executive Director, Global Micro Quality and Sterility Assurance at Merck). This candid conversation reveals why this industry event is so influential…and always sold out!
PharmExec
OCTOBER 10, 2024
Data from the Phase III AReSVi-006 clinical trial found that Arexvy offered a cumulative efficacy of 62.9% against lower respiratory tract disease caused by respiratory syncytial virus.
PharmaTech
OCTOBER 10, 2024
Get a glimpse of the power and popularity behind the PDA Pharmaceutical Microbiology Conference from two planning committee members, Julia Marre, PhD (Associate Director, Scientific and Regulatory Affairs at Pocket Naloxone Corp) and Dawn Watson (Executive Director, Global Micro Quality and Sterility Assurance at Merck). This candid conversation reveals why this industry event is so influential…and always sold out!
Salesforce
OCTOBER 10, 2024
The healthcare and life sciences (HLS) industry is experiencing a rapid digital transformation. From advancements in personalized medicine to the integration of AI and IoT, the potential for innovation is immense. HLS organizations are feeling the pressure to adopt new technologies that improve patient care , boost operational efficiency, and make better use of data.
Advertisement
Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A
Expert insights. Personalized for you.
279 
Let's personalize your content